Canada markets open in 6 hours

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.09-0.09 (-0.98%)
At close: 04:00PM EDT
9.09 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 247.43M
Enterprise Value 265.12M
Trailing P/E N/A
Forward P/E 29.33
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.37
Price/Book (mrq)84.82
Enterprise Value/Revenue 12.47
Enterprise Value/EBITDA -21.44

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 312.92%
S&P500 52-Week Change 323.57%
52 Week High 311.92
52 Week Low 36.30
50-Day Moving Average 310.02
200-Day Moving Average 38.95

Share Statistics

Avg Vol (3 month) 3135.65k
Avg Vol (10 day) 3142.6k
Shares Outstanding 527.1M
Implied Shares Outstanding 627.22M
Float 815.29M
% Held by Insiders 114.60%
% Held by Institutions 155.25%
Shares Short (Apr 15, 2024) 41.87M
Short Ratio (Apr 15, 2024) 411.45
Short % of Float (Apr 15, 2024) 49.78%
Short % of Shares Outstanding (Apr 15, 2024) 46.91%
Shares Short (prior month Mar 15, 2024) 41.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -75.50%
Operating Margin (ttm)-18.67%

Management Effectiveness

Return on Assets (ttm)-29.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)21.25M
Revenue Per Share (ttm)0.80
Quarterly Revenue Growth (yoy)534.20%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-16.05M
Diluted EPS (ttm)-0.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.27M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)30.95M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.56
Book Value Per Share (mrq)-0.43

Cash Flow Statement

Operating Cash Flow (ttm)-17.14M
Levered Free Cash Flow (ttm)-12.35M